The Experience of Giving Birth With Remifentanil for Pain Relief: A Qualitative Study of Mothers and Midwives
NCT ID: NCT07030777
Last Updated: 2025-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2025-03-01
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark.
Objective:
This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives.
Methods:
A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour
NCT00202722
Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil
NCT07167498
Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth
NCT02447757
Intravenous Remifentanil for Labor Analgesia
NCT00710086
Remifentanil vs. Combined Spinal-epidural Analgesia for Labor Analgesia and Progress of Labor in Multiparous
NCT02963337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midwifes
Group 1: Midwives This group includes licensed midwives who have administered remifentanil for pain relief during labor. Participants will be interviewed about their experiences with providing care during remifentanil-supported childbirth, including perceptions of efficacy, safety, and clinical workflow.
No interventions assigned to this group
Laboring Women
Group 2: Laboring Women This group consists of women who gave birth using remifentanil patient-controlled analgesia (PCA) for pain relief during labor. Participants will be interviewed about their lived experience of pain management, decision-making, and overall birth experience using remifentanil.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Midwives who participate in childbirths where remifentanil is used as pain relief.
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nordsjaellands Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patricia Duch
M.D. Consultant, obstetric anaesthetist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Duch, MD
Role: STUDY_CHAIR
Department of Anaesthesia, Copenhagen University Hospital, North Zealand, Hillerød, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Copenhagen, North Zealand Hospital
Hillerød, Select State, Denmark
Department of Anaesthesia and Intensive care, University Hospital of Southern Denmark, Kolding, Denmark
Kolding, , Denmark
Præhospital center
Næstved, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.